Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer’s disease: do we need new inhibitors?

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.10, Iss.4, 2005-11, pp. : 817-825

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite

From Traditional European Medicine to Discovery of New Drug Candidates for the Treatment of Dementia and Alzheimer's Disease: Acetylcholinesterase Inhibitors

Current Medicinal Chemistry, Vol. 20, Iss. 8, 2013-03 ,pp. : 976-983

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimers Disease

By Jönsson L.

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the context of therapeutic strategies to combat Alzheimer’s disease

By Recanatini Maurizio Cavalli Andrea

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 12, 2002-12 ,pp. : 1853-1865

Informa Healthcare

Access to resources Recommend Favorite

QSAR Applications During Last Decade on Inhibitors of Acetylcholinesterase in Alzheimer's Disease

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-09 ,pp. : 936-946

Bentham Science Publishers

Access to resources Recommend Favorite